Repositories list

• TutorialDemo2024

  Public
  A demonstration of the HADES open source tools

  HTML

  •0•0•0•0•Updated Oct 18, 2024Oct 18, 2024

• PandemicPrediction

  Public
  Validating the COVID prediction models across time and databases

  R

  •0•1•0•0•Updated Oct 18, 2024Oct 18, 2024

• StrategusStudyRepoTemplate

  Public template
  Strategus study repository template

  R

  •

  Apache License 2.0

  •1•0•0•0•Updated Oct 17, 2024Oct 17, 2024

• MyositisNetworkStudy

  Public
  OHDSI Network Study lead by John Hopkins Myositis Group

  R

  •

  Apache License 2.0

  •0•2•0•0•Updated Oct 15, 2024Oct 15, 2024

• SemaglutideNaion

  Public
  OHDSI network study for population-level effect estimation of risk of NAION and other vision disorders from exposure to semaglutide.

  R

  •3•2•2•1•Updated Oct 15, 2024Oct 15, 2024

• ExternalValidation

  Public
  Methods research investigating a way to estimate external validation using summary statistics

  R

  •0•1•0•0•Updated Oct 15, 2024Oct 15, 2024

• Glp1Dili

  Public
  TeX

  •0•0•0•0•Updated Oct 6, 2024Oct 6, 2024

• LegendT2dm

  Public
  R

  •15•9•5•1•Updated Oct 1, 2024Oct 1, 2024

• CHAPTER

  Public
  Characterization of Health by OHDSI Asia-Pacific chapter to identify Temporal Effect of the Pandemic

  R

  •1•0•3•1•Updated Sep 20, 2024Sep 20, 2024

• LegendT2dmEvidenceExplorer

  Public
  LEGEND-T2DM Evidence Explorer

  R

  •2•1•0•0•Updated Sep 19, 2024Sep 19, 2024

• DeepLearningComparison

  Public
  Investigating different deep learning approaches

  R

  •3•4•0•0•Updated Sep 6, 2024Sep 6, 2024

• Troy

  Public
  R

  •2•0•0•0•Updated Aug 30, 2024Aug 30, 2024

• OhdsiEvidenceNetwork

  Public
  R

  •1•1•2•0•Updated Aug 13, 2024Aug 13, 2024

• IbdCharacterization

  Public
  Characterization study of inflammatory bowel disease

  R

  •

  Apache License 2.0

  •2•1•2•0•Updated Jul 23, 2024Jul 23, 2024

• Glp1ClrdEstimation

  Public
  R

  •1•1•1•0•Updated Jul 19, 2024Jul 19, 2024

• SAGE

  Public
  R

  •

  Apache License 2.0

  •1•0•0•0•Updated Jul 9, 2024Jul 9, 2024

• PhenoPhebStemiCharacterization

  Public
  This comprehensive study aims to understand STEMI patients’ characteristics and identify the incidence rates across multiple real-world data datasets.

  R

  •1•0•0•0•Updated Jul 2, 2024Jul 2, 2024

• QbaEvaluation

  Public
  Empirically evaluates QBA for outcome phenotype error correction in several pharmacoepidemiologic comparative effect estimation scenarios. Simulates an analytic space defined by outcome incidence proportions, observed effect estimates, and phenotype measurement errors to determine which QBA input combinations produce valid results.

  HTML

  •0•0•0•0•Updated Jun 19, 2024Jun 19, 2024

• FluoroquinoloneAorticAneurysm

  Public
  [under development]

  R

  •9•1•3•0•Updated Jun 19, 2024Jun 19, 2024

• OsteoporosisTreatmentPathways

  Public
  In this study,we evaluate the changes in osteoporosis medication treatment patterns in postmenopausal women.

  R

  •1•0•0•0•Updated Jun 18, 2024Jun 18, 2024

• MotherInfantLinkEval

  Public
  This research developed and evaluated an algorithm to link mothers and infants in two US administrative databases to facilitate research on prenatal medication exposure and infant health outcomes.

  R

  •

  Apache License 2.0

  •1•0•0•0•Updated Jun 17, 2024Jun 17, 2024

• glp1HIRA

  Public
  R

  •0•1•0•0•Updated May 15, 2024May 15, 2024

• LegendHtnStepCare

  Public
  TeX

  •2•0•0•1•Updated May 13, 2024May 13, 2024

• DdiPpiClo

  Public
  A study package to investigate drug-drug interaction between Proton pump inhibitor and Clopidogrel

  R

  •2•0•1•0•Updated Apr 12, 2024Apr 12, 2024

• HowOften

  Public
  [under development] Large-scale incidence characterization

  HTML

  •9•6•2•1•Updated Apr 11, 2024Apr 11, 2024

• Eumaeus

  Public
  Evaluating Use of Methods for Adverse Event Under Surveillance (for vaccines)

  HTML

  •3•2•0•0•Updated Apr 2, 2024Apr 2, 2024

• CovidVaccineRapidCycleAnalyses

  Public
  Rapid real-world data analyses for near real-time monitoring of the safety of the Janssen COVID vaccine.

  R

  •0•0•0•0•Updated Mar 29, 2024Mar 29, 2024

• PhePheb2024

  Public
  Phenotype Phebruary 2024 package for Cohort Diagnostics and Cohort Incidence

  R

  •0•0•0•0•Updated Feb 24, 2024Feb 24, 2024

• LegendT2dmCohortExplorer

  Public
  R

  •1•0•0•0•Updated Feb 19, 2024Feb 19, 2024

• EhdenAlopecia

  Public
  R

  •

  Apache License 2.0

  •2•0•0•1•Updated Feb 19, 2024Feb 19, 2024